These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5088348)

  • 1. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy.
    Baron JB; Rivoalan Y; Morel P
    Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ophthalmologic study of patients receiving psychotropic drugs].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196
    [No Abstract]   [Full Text] [Related]  

  • 5. Lens changes associated with long-term psychotropica therapy.
    Setogawa T; Tamai A; Matsuura H; Ogura C
    Yonago Acta Med; 1975 Aug; 19(2):103-9. PubMed ID: 1232695
    [No Abstract]   [Full Text] [Related]  

  • 6. Ocular changes produced by chlorpromazine.
    Dencker SJ; Enoksson P
    Acta Ophthalmol (Copenh); 1966; 44(3):397-403. PubMed ID: 5953234
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pigmentation of the skin: rare side effect, following the prolonged administration of high doses of chlorpromazine].
    Lehmann HE; Gallai Z; Ban TA
    Ann Dermatol Syphiligr (Paris); 1965; 92(3):287-9. PubMed ID: 5841181
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular changes associated with chlorpromazine therapy. A preliminary report.
    Edler K
    Acta Ophthalmol (Copenh); 1966; 44(3):405-9. PubMed ID: 5953235
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular complications of phenothiazines.
    Mathalone MB
    Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
    [No Abstract]   [Full Text] [Related]  

  • 10. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorpromazine-induced cutaneous pigmentation--effect of replacement with clozapine.
    Lal S; Lal S
    J Psychiatry Neurosci; 2000 May; 25(3):281. PubMed ID: 10863889
    [No Abstract]   [Full Text] [Related]  

  • 12. Blue skin pigmentation and chlorpromazine.
    Haddad RI
    J Ky Med Assoc; 1977 Mar; 75(3):124-6. PubMed ID: 839129
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ophthalmologic manifestations, with or without associated skin disorders, during prolonged treatment with chlorpromazine].
    Baron JB; Morel P; Rivoallan Y; Soulairac A
    Agressologie; 1968; 9(2):293-304. PubMed ID: 5675496
    [No Abstract]   [Full Text] [Related]  

  • 14. Ocular (pigmentary) effects of psychotropic drugs.
    Appleton WS; Shader RI; DiMascio A
    Conn Med; 1970 Jan; 34(1):25-8. PubMed ID: 4903792
    [No Abstract]   [Full Text] [Related]  

  • 15. Kerato-lenticular ocular deposits and visual impairment with prolonged chlorpromazine use: A case series.
    Gowda GS; Hegde A; Shanbhag V; Narayanaswamy JC; Jaisoorya TS
    Asian J Psychiatr; 2017 Feb; 25():188-190. PubMed ID: 28262147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal deposition after high-dose chlorpromazine hydrochloride therapy.
    Webber SK; Domniz Y; Sutton GL; Rogers CM; Lawless MA
    Cornea; 2001 Mar; 20(2):217-9. PubMed ID: 11248834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; BERRY K
    Can Med Assoc J; 1964 Mar; 90(11):663-5. PubMed ID: 14127375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SKIN PIGMENTATION, CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE TREATMENT.
    MASSEY LW
    Can Med Assoc J; 1965 Jan; 92(4):186-7. PubMed ID: 14232196
    [No Abstract]   [Full Text] [Related]  

  • 20. Resolution of chlorpromazine-induced pigmentation with haloperidol substitution.
    Thompson TR; Lal S; Yassa R; Gerstein W
    Acta Psychiatr Scand; 1988 Dec; 78(6):763-5. PubMed ID: 3223334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.